Fred E Cooperrider

Array ( [id] => 7329869 [patent_doc_number] => 20040254139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Oligonucleotides antagonist for human tumor necrosis factor alpha (TNF-alpha)' [patent_app_type] => new [patent_app_number] => 10/822761 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5670 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254139.pdf [firstpage_image] =>[orig_patent_app_number] => 10822761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406101 [patent_doc_number] => 20040175828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Human RNase III and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/805919 [patent_app_country] => US [patent_app_date] => 2004-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12127 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175828.pdf [firstpage_image] =>[orig_patent_app_number] => 10805919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813760 [patent_doc_number] => 07414033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Modulation of diacylglycerol acyltransferase 1 expression' [patent_app_type] => utility [patent_app_number] => 10/803482 [patent_app_country] => US [patent_app_date] => 2004-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26902 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414033.pdf [firstpage_image] =>[orig_patent_app_number] => 10803482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608014 [patent_doc_number] => 20060269530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'RNA interference compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/552914 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24095 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269530.pdf [firstpage_image] =>[orig_patent_app_number] => 10552914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7325211 [patent_doc_number] => 20040138158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon' [patent_app_type] => new [patent_app_number] => 10/469091 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8930 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138158.pdf [firstpage_image] =>[orig_patent_app_number] => 10469091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020380 [patent_doc_number] => 20050222399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'BIOINFORMATICALLY DETECTABLE GROUP OF NOVEL REGULATORY OLIGONUCLEOTIDES ASSOCIATED WITH ALZHEIMER\'S DISEASE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 10/708204 [patent_app_country] => US [patent_app_date] => 2004-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 28979 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222399.pdf [firstpage_image] =>[orig_patent_app_number] => 10708204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556235 [patent_doc_number] => 07468356 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-23 [patent_title] => 'Modulation of insulin like growth factor I receptor expression' [patent_app_type] => utility [patent_app_number] => 10/545354 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 32021 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468356.pdf [firstpage_image] =>[orig_patent_app_number] => 10545354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675251 [patent_doc_number] => 20040126867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Human RNase III and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/774974 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12138 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126867.pdf [firstpage_image] =>[orig_patent_app_number] => 10774974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 500921 [patent_doc_number] => 07205283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Antisense oligonucleotides that inhibit expression of HIF-1' [patent_app_type] => utility [patent_app_number] => 10/766185 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9388 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205283.pdf [firstpage_image] =>[orig_patent_app_number] => 10766185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089658 [patent_doc_number] => 20050009771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same' [patent_app_type] => utility [patent_app_number] => 10/764503 [patent_app_country] => US [patent_app_date] => 2004-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 59846 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009771.pdf [firstpage_image] =>[orig_patent_app_number] => 10764503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323693 [patent_doc_number] => 20040137501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Antisense modulation of TRADD expression' [patent_app_type] => new [patent_app_number] => 10/765500 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16240 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137501.pdf [firstpage_image] =>[orig_patent_app_number] => 10765500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136556 [patent_doc_number] => 20050181376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Antisense modulation of microsomal triglyceride transfer protein expression' [patent_app_type] => utility [patent_app_number] => 10/759618 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26444 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181376.pdf [firstpage_image] =>[orig_patent_app_number] => 10759618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674433 [patent_doc_number] => 20040127685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Novel molecules of the card-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 10/756097 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 35895 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127685.pdf [firstpage_image] =>[orig_patent_app_number] => 10756097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119295 [patent_doc_number] => 20070141009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Sirna mediated post-transriptional gene silencing of genes involved in alopecia' [patent_app_type] => utility [patent_app_number] => 10/544320 [patent_app_country] => US [patent_app_date] => 2004-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26955 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141009.pdf [firstpage_image] =>[orig_patent_app_number] => 10544320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432354 [patent_doc_number] => 20040162257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells' [patent_app_type] => new [patent_app_number] => 10/735512 [patent_app_country] => US [patent_app_date] => 2003-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6281 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162257.pdf [firstpage_image] =>[orig_patent_app_number] => 10735512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323620 [patent_doc_number] => 20040137485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Antisense antibacterial method and composition' [patent_app_type] => new [patent_app_number] => 10/719633 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19653 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137485.pdf [firstpage_image] =>[orig_patent_app_number] => 10719633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672932 [patent_doc_number] => 20040180847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Antisense modulation of kinesin-like 1 expression' [patent_app_type] => new [patent_app_number] => 10/714796 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26854 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180847.pdf [firstpage_image] =>[orig_patent_app_number] => 10714796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346720 [patent_doc_number] => 20040192629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Allele-specific RNA interference' [patent_app_type] => new [patent_app_number] => 10/700816 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16765 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192629.pdf [firstpage_image] =>[orig_patent_app_number] => 10700816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428083 [patent_doc_number] => 20040161777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Modified oligonucleotides for use in RNA interference' [patent_app_type] => new [patent_app_number] => 10/700930 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38128 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161777.pdf [firstpage_image] =>[orig_patent_app_number] => 10700930 [rel_patent_id] =>[rel_patent_doc_number] =>)